Profile picture

Doctor Samuele Ambrosini

University of Zurich, Schlieren (Switzerland)
Follow
Logo ESC

Contributor content

The histone methyltransferase SETD2 drives cardiometabolic heart failure with preserved ejection fraction
Presentation
The histone methyltransferase SETD2 drives cardiometabolic heart failure with preserved ejection fraction
Read more
A methylation-dependent checkpoint by SETD7 promotes myocardial ischemic injury in mice and men
Presentation
A methylation-dependent checkpoint by SETD7 promotes myocardial ischemic injury in mice and men
Read more
Targeting the methyltransferase setd7 prevents myocardial ischemic injury: a translational study
Presentation
Targeting the methyltransferase setd7 prevents myocardial ischemic injury: a translational study
Read more
Methylation of the hippo signalling effector YAP by SETD7 drives myocardial ischemic injury
Presentation
Methylation of the hippo signalling effector YAP by SETD7 drives myocardial ischemic injury
Read more
The methyltransferase SETD7 promotes myocardial ischemic injury by activating Hippo signalling
Presentation
The methyltransferase SETD7 promotes myocardial ischemic injury by activating Hippo signalling
Read more

ESC 365 is supported by

novartis Explore sponsored resources